Lymphocytic colitis secondary to ipilimumab treatment

Inflamm Bowel Dis. 2013 Feb;19(2):E15-6. doi: 10.1002/ibd.22846.
No abstract available

Publication types

  • Case Reports
  • Letter

MeSH terms

  • Aged
  • Antibodies, Monoclonal / adverse effects*
  • Antineoplastic Agents / adverse effects*
  • Colitis, Lymphocytic / chemically induced*
  • Colitis, Lymphocytic / diagnosis
  • Humans
  • Ipilimumab
  • Male

Substances

  • Antibodies, Monoclonal
  • Antineoplastic Agents
  • Ipilimumab